Quality Leadership LYSI demonstrates strong QA and GMP-compliance with an in-house lab and a state-of-the-art processing plant. This emphasis on product safety and regulatory alignment signals a potential for partnerships in high-purity omega-3 and specialty fish oil products, including contract manufacturing or API-grade collaborations.

Research Driven The company positions itself as a leader in omega-3 research with extensive collaboration with global research bodies. This creates opportunities for joint R&D ventures, co-branded nutraceutical initiatives, or early-access programs for innovative omega-3 formulations.

Product Portfolio LYSI offers a broad portfolio including cod liver oil, omega-3 fish oil, salmon oil, tuna oil, shark liver oil, capelin oil, squalene and fish meal. This enables cross-selling to customers seeking diverse marine-derived ingredients or turnkey blends for dietary supplements, pharmaceuticals, or feed applications.

Scale & Reach With revenue in the mid-to-high billions and a workforce of up to approximately 200 employees, LYSI has significant scale and market presence in Iceland and potentially broader export markets, suggesting opportunities for regional distribution partnerships, bulk ingredient sourcing, and supply chain collaborations.

Regulatory Footprint IMCA GMP (API) licensing and rigorous QA signals favorable regulatory risk profiles for customers requiring compliant supply, making LYSI a strong candidate for validated supply agreements, private-label partnerships, or contract manufacturing for regulated products.